Major infections in a cohort of 120 patients with juvenile-onset systemic lupus erythematosus

被引:30
作者
Costa-Reis, Patricia [1 ,2 ,3 ]
Nativ, Simona [1 ]
Isgro, Josephine [1 ]
Rodrigues, Teresa [4 ]
Yildirim-Toruner, Cagri [1 ]
Starr, Amy [1 ]
Saiman, Lisa [5 ]
Lmundo, Lisa [1 ]
Eichenfield, Andrew [1 ]
机构
[1] Columbia Univ, Morgan Stanley Childrens Hosp, New York Presbyterian Hosp, Med Ctr,Div Pediat Rheumatol, New York, NY 10027 USA
[2] Hosp Santa Maria, Ctr Hosp Lisboa Norte, Lisbon, Portugal
[3] Univ Lisbon, Fac Med, Lisbon, Portugal
[4] Univ Lisbon, Fac Med, Lab Biomatemat, Lisbon, Portugal
[5] Columbia Univ, Morgan Stanley Childrens Hosp, New York Presbyterian Hosp, Med Ctr,Div Infect Dis, New York, NY 10027 USA
关键词
Systemic lupus erythematosus; SLE; Lupus; Infections; RHEUMATOLOGY DAMAGE INDEX; RISK-FACTORS; HERPES-ZOSTER; CYTOMEGALOVIRUS-INFECTION; SINGLE COHORT; CLASSIFICATION; SALMONELLOSIS; BACTEREMIA; MORTALITY; ADULTS;
D O I
10.1016/j.clim.2013.08.009
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In order to describe the incidence and characteristics of major infections in juvenile-onset systemic lupus erythematosus (jSLE), we studied a cohort of 120 patients (51% Hispanic and 28% African American, 49% with renal involvement and 12% with neuropsychiatric manifestations). There were 101 major infections affecting 44 patients (37%) for an incidence of 169/1000 patient-years of follow-up. Active disease at jSLE diagnosis, renal involvement, neuropsychiatric manifestations, higher cumulative dose of prednisone, and treatment with cyclophosphamide or mycophenolate mofetil were all associated with major infection (p < 0.05). By logistic regression, the combined effect of treatment with cyclophosphamide and cumulative dose of prednisone was associated with major infection (p = 0.04). Two patients died, one due to cytomegalovirus infection. Major infection was associated with damage (p = 0.004). In conclusion, in a large cohort of jSLE patients, major infections were common, were associated with active disease and its treatment, and resulted in noteworthy morbidity. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:442 / 449
页数:8
相关论文
共 32 条
  • [1] Infections in the lupus patient: perspectives on prevention
    Barber, Claire
    Gold, Wayne L.
    Fortin, Paul R.
    [J]. CURRENT OPINION IN RHEUMATOLOGY, 2011, 23 (04) : 358 - 365
  • [2] Incidence, Risk Factors, and Outcome of Herpes Zoster in Systemic Lupus Erythematosus
    Borba, Eduardo F.
    Ribeiro, Ana C. M.
    Martin, Patricia
    Costa, Luciana P.
    Guedes, Lissiane K. N.
    Bonfa, Eloisa
    [J]. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2010, 16 (03) : 119 - 122
  • [3] Infections in systemic lupus erythematosus:: a prospective and controlled study of 110 patients
    Bosch, X.
    Guilabert, A.
    Pallares, L.
    Cervera, R.
    Ramos-Casals, M.
    Bove, A.
    Ingelmo, M.
    Font, J.
    [J]. LUPUS, 2006, 15 (09) : 584 - 589
  • [4] Morbidity and mortality in systemic lupus erythematosus during a 10-year period -: A comparison of early and late manifestations in a cohort of 1,000 patients
    Cervera, R
    Khamashta, MA
    Font, J
    Sebastiani, GD
    Gil, A
    Lavilla, P
    Mejía, JC
    Aydintug, AC
    Chwalinska-Sadowska, H
    de Ramón, E
    Fernández-Nebro, A
    Galeazzi, M
    Valen, M
    Mathieu, A
    Houssiau, FD
    Caro, N
    Alba, P
    Ramos-Casals, M
    Ingelmo, M
    Hughes, GRV
    [J]. MEDICINE, 2003, 82 (05) : 299 - 308
  • [5] The Euro-lupus project: epidemiology of systemic lupus erythematosus in Europe
    Cervera, R.
    Khamashta, M. A.
    Hughes, G. R. V.
    [J]. LUPUS, 2009, 18 (10) : 869 - 874
  • [6] Long-term outcome and short-term survival of patients with systemic lupus erythematosus after bacteraemia episodes: 6-yr follow-up
    Chen, M. -J.
    Tseng, H. -M.
    Huang, Y. -L.
    Hsu, W. -N.
    Yeh, K. -W.
    Wu, T. -L.
    See, L. -C.
    Huang, J. -L.
    [J]. RHEUMATOLOGY, 2008, 47 (09) : 1352 - 1357
  • [7] Rates of, and risk factors for, severe infections in patients with systemic autoimmune diseases receiving biological agents off-label
    Diaz-Lagares, Candido
    Perez-Alvarez, Roberto
    Garcia-Hernandez, Francisco J.
    Ayala-Gutierrez, Maria M.
    Luis Callejas, Jose
    Martinez-Berriotxoa, Agustin
    Rascon, Javier
    Caminal-Montero, Luis
    Selva-O'Callaghan, Albert
    Oristrell, Joaquim
    Hidalgo, Carmen
    Gomez-de-la-Torre, Ricardo
    Saez, Luis
    Canora-Lebrato, Jesus
    Camps, Maria-Teresa
    Ortego-Centeno, Norberto
    Castillo-Palma, Maria-Jesus
    Ramos-Casals, Manuel
    [J]. ARTHRITIS RESEARCH & THERAPY, 2011, 13 (04)
  • [8] Inadequate Antimicrobial Treatment for Nosocomial Infection is a Mortality Risk Factor for Systemic Lupus Erythematous Patients Admitted to Intensive Care Unit
    Feng, Po-Hao
    Lin, Shu-Min
    Yu, Chih-Teng
    Yu, Kuang-Hui
    Huang, Chien-Da
    Tsai, Ying-Huang
    Kuo, Han-Pin
    [J]. AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2010, 340 (01) : 64 - 68
  • [9] The development and initial validation of the systemic lupus international collaborating clinics American College of Rheumatology Damage Index for Systemic Lupus Erythematosus
    Gladman, D
    Ginzler, E
    Goldsmith, C
    Fortin, P
    Liang, M
    Urowitz, M
    Bacon, P
    Bombardieri, S
    Hanly, J
    Hay, E
    Isenberg, D
    Jones, J
    Kalunian, K
    Maddison, P
    Nived, O
    Petri, M
    Richter, M
    SanchezGuerrero, J
    Snaith, M
    Sturfelt, G
    Symmons, D
    Zoma, A
    [J]. ARTHRITIS AND RHEUMATISM, 1996, 39 (03): : 363 - 369
  • [10] The reliability of the systemic Lupus International Collaborating Clinics American College of Rheumatology Damage Index in patients with Systemic Lupus Erythematosus
    Gladman, DD
    Urowitz, MB
    Goldsmith, CH
    Fortin, P
    Ginzler, E
    Gordon, C
    Hanly, JG
    Isenberg, DA
    Kalunian, K
    Nived, O
    Petri, M
    SanchezGuerrero, J
    Snaith, M
    Sturfelt, G
    [J]. ARTHRITIS AND RHEUMATISM, 1997, 40 (05): : 809 - 813